/ZRSEF
ZRSEF Stock - DocMorris AG
Healthcare|Medical - PharmaceuticalsOTC
$10.24+0.00%
+$0.00 (+0.00%) • Dec 19
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.49
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $11.26
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ZRSEF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$10.13 – $10.34
TARGET (TP)$11.77
STOP LOSS$9.42
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.78
52W High$90.00
52W Low$10.24
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.02B | $969.46M | $930.97M | $1.73B | $1.48B |
| Gross Profit | $216.54M | $203.35M | $160.15M | $260.05M | $241.33M |
| Gross Margin | 21.3% | 21.0% | 17.2% | 15.1% | 16.3% |
| Operating Income | $-104,223,000 | $89.70M | $40.49M | $106.81M | $-117,633,000 |
| Net Income | $-97,253,000 | $82.28M | $-171,115,000 | $-225,735,000 | $-135,695,000 |
| Net Margin | -9.6% | 8.5% | -18.4% | -13.1% | -9.2% |
| EPS | $-8.25 | $6.99 | $-15.88 | $-23.40 | $-14.95 |
Company Overview
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers consumer health, beauty, and personal care products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. The company was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ZRSEFBeat Rate
0%
Last 9 quarters
Avg Surprise
-197.8%
EPS vs Estimate
Beats / Misses
0/9
Last 12 quarters
Latest EPS
$-2.66
Q2 2025
EPS Surprise History
Q4 21
-303.0%
$-16.81vs$-4.17
Q4 22
-67.2%
$-8.65vs$-5.18
Q4 22
-142.2%
$-8.21vs$-3.39
Q2 23
-797.8%
$-5.18vs$-0.58
Q4 23
-129.6%
$-5.89vs$-2.57
Q2 24
-26.7%
$-3.59vs$-2.84
Q4 24
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2026 | Aug 19, 2026 | — | — | — | — |
Q1 2026 | Mar 11, 2026 | — | — | — | — |
Q2 2025 | Jun 30, 2025 | — | $-2.66 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-5.54 | — | — |
Q2 2024 | Jun 29, 2024 | $-2.84 | $-3.59 | -26.7% | ✗ MISS |
Q4 2023 | Dec 31, 2023 | $-2.57 | $-5.89 | -129.6% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $-0.58 | $-5.18 | -797.8% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-3.39 | $-8.21 | -142.2% | ✗ MISS |
Q4 2022 | Oct 20, 2022 | $-5.18 | $-8.65 | -67.2% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | $-4.17 | $-16.81 | -303.0% | ✗ MISS |
Q2 2021 | Jun 14, 2021 | $-4.01 | $-8.69 | -116.7% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | — | $-9.84 | — | — |
Q4 2020 | Oct 21, 2020 | — | $-6.38 | — | — |
Q1 2020 | Mar 19, 2020 | $-3.03 | $-4.14 | -36.9% | ✗ MISS |
Q3 2019 | Aug 21, 2019 | — | $-2.01 | — | — |
Q2 2019 | Apr 17, 2019 | — | $-3.38 | — | — |
Q3 2018 | Aug 15, 2018 | — | $-2.84 | — | — |
Q1 2018 | Mar 21, 2018 | — | $-3.00 | — | — |
Q3 2017 | Aug 23, 2017 | $-1.61 | $-4.19 | -160.1% | ✗ MISS |
Q2 2017 | Apr 11, 2017 | — | $-3.89 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ZRSEF
What is ZRSEF's current stock price?
DocMorris AG (ZRSEF) is currently trading at $10.24 per share. The stock has moved +0.00% today.
What is the analyst price target for ZRSEF?
No analyst price targets are currently available for this stock.
What sector is DocMorris AG in?
DocMorris AG operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.
What is ZRSEF's market cap?
DocMorris AG has a market capitalization of $0.50 billion, making it a small-cap company.
Does ZRSEF pay dividends?
No, DocMorris AG does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorDRWKF
Drägerwerk AG & Co. KGaA
$77.21
Mkt Cap: $1.4B
EBOSY
EBOS Group Limited
$35.03
Mkt Cap: $1.7B
HTSUY
Hisamitsu Pharmaceutical Co., Inc.
$6.65
Mkt Cap: $1.9B
MEOBF
Mesoblast Limited
$1.35
Mkt Cap: $1.7B
ONTTF
Oxford Nanopore Technologies plc
$1.72
Mkt Cap: $1.7B
RTEZ
Rest Ez Inc.
$70.00
Mkt Cap: $1.9B
SAEYY
Redcare Pharmacy N.V.
$7.50
Mkt Cap: $1.5B
SHPPF
Redcare Pharmacy N.V.
$75.00
Mkt Cap: $1.5B
STSEY
Stratec SE
$5.10
Mkt Cap: $1.5B
SZUKF
Suzuken Co., Ltd.
$30.30
Mkt Cap: $1.7B
Explore stocks similar to ZRSEF for comparison